{"nctId":"NCT00323284","briefTitle":"A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma","startDateStruct":{"date":"2005-06"},"conditions":["Open-Angle Glaucoma"],"count":240,"armGroups":[{"label":"A--iStent plus Cataract Surgery","type":"ACTIVE_COMPARATOR","interventionNames":["Device: iStent plus Cataract Surgery"]},{"label":"B--Cataract Surgery Only","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Cataract surgery only"]}],"interventions":[{"name":"iStent plus Cataract Surgery","otherNames":["iStent Surgery"]},{"name":"Cataract surgery only","otherNames":["Phacoemulsification"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosed with open-angle glaucoma (OAG) in the study eye. Pseudoexfoliative and pigmentary glaucoma are also acceptable diagnoses.\n* Subject on at least one glaucoma medication\n* Able and willing to attend follow up visits for two years post operative\n* Able and willing to sign informed consent\n\nExclusion Criteria:\n\n* Prior glaucoma procedures (eg trabeculectomy, viscocanalostomy, ALT, SLT, shunt implant, collagen implant, cyclo destructive procedures etc)\n* Angle closure glaucoma\n* Fellow eye already enrolled","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Intraocular Pressure (Measured in mm Hg) Less or Equal to 21 mm Hg on no Topical Hypotensive Meds","description":"Subjects with an intraocular pressure (IOP) less than or equal to 21 mm Hg without use of topical hypotensive medication at 12 months","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"50","spread":null}]}]}]},{"type":"SECONDARY","title":"Efficacy","description":"Subjects with an intraocular pressure (IOP) reduction from baseline of greater than or equal to 20% without use of topical hypotensive medication at 12 months","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"64","spread":null},{"groupId":"OG001","value":"47","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":116},"commonTop":["Early post-op corneal edema","Posterior capsular opacification","Any BCVA loss greater than 1 line of vision at or after the 3 month visit","Blurry vision or visual disturbance"]}}}